GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.
Arvid RongveAree WitoelarAgustín RuizLavinia AthanasiuCarla AbdelnourJordi ClarimonStefanie Heilmann-HeimbachIsabel HernándezSonia Moreno-GrauItziar de RojasEstrella Morenas-RodríguezTormod FladbySigrid B SandoGeir BråthenFrédéric BlancOlivier BousigesAfina W LemstraInger van SteenovenElisabet LondosIna S AlmdahlLene PålhaugenJon A EriksenSrdjan DjurovicEystein StordalIngvild SaltvedtIngun D UlsteinFrancesco BettellaRahul S DesikanAne-Victoria IdlandMathias ToftLasse PihlstromJon SnaedalLluís TárragaMercè BoadaAlberto LleóHreinn StefánssonKári StefánssonAlfredo RamirezDag AarslandOle A AndreassenPublished in: Scientific reports (2019)
Dementia with Lewy Bodies (DLB) is a common neurodegenerative disorder with poor prognosis and mainly unknown pathophysiology. Heritability estimates exceed 30% but few genetic risk variants have been identified. Here we investigated common genetic variants associated with DLB in a large European multisite sample. We performed a genome wide association study in Norwegian and European cohorts of 720 DLB cases and 6490 controls and included 19 top-associated single-nucleotide polymorphisms in an additional cohort of 108 DLB cases and 75545 controls from Iceland. Overall the study included 828 DLB cases and 82035 controls. Variants in the ASH1L/GBA (Chr1q22) and APOE ε4 (Chr19) loci were associated with DLB surpassing the genome-wide significance threshold (p < 5 × 10-8). One additional genetic locus previously linked to psychosis in Alzheimer's disease, ZFPM1 (Chr16q24.2), showed suggestive association with DLB at p-value < 1 × 10-6. We report two susceptibility loci for DLB at genome-wide significance, providing insight into etiological factors. These findings highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.
Keyphrases
- genome wide
- genome wide association study
- copy number
- poor prognosis
- dna methylation
- cognitive decline
- parkinson disease
- long non coding rna
- cognitive impairment
- type diabetes
- gene expression
- metabolic syndrome
- late onset
- high fat diet
- insulin resistance
- mass spectrometry
- genome wide association
- skeletal muscle
- high resolution